On April 4, the Centers for Medicare and Medicaid Services (CMS) issued a final rule regarding “Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly.” The rule included a statement that CMS did not intend to finalize “Part D Coverage of Anti-Obesity Medications (AOMs),” meaning Medicare and Medicaid would not cover AOMs in Contract Year 2026. CMS noted it would “continue to consider the extent to which it may be appropriate to engage in future rulemaking in this area.”